Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children

The malaria vaccine candidate, RTS,S/AS01(E), showed promising protective efficacy in a trial of Kenyan and Tanzanian children aged 5 to 17 months. Here we report on the vaccine's safety and tolerability. The experimental design was a Phase 2b, two-centre, double-blind (observer- and participan...

Descripción completa

Detalles Bibliográficos
Autores principales: Lusingu, John, Olotu, Ally, Leach, Amanda, Lievens, Marc, Vekemans, Johan, Olivier, Aurélie, Benns, Sarah, Olomi, Raimos, Msham, Salum, Lang, Trudie, Gould, Jayne, Hallez, Karin, Guerra, Yolanda, Njuguna, Patricia, Awuondo, Ken O., Malabeja, Anangisye, Abdul, Omar, Gesase, Samwel, Dekker, Denise, Malle, Lincoln, Ismael, Sadiki, Mturi, Neema, Drakeley, Chris J., Savarese, Barbara, Villafana, Tonya, Ballou, W. Ripley, Cohen, Joe, Riley, Eleanor M., Lemnge, Martha M., Marsh, Kevin, Bejon, Philip, von Seidlein, Lorenz
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993932/
https://www.ncbi.nlm.nih.gov/pubmed/21124768
http://dx.doi.org/10.1371/journal.pone.0014090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993932/
https://www.ncbi.nlm.nih.gov/pubmed/21124768
http://dx.doi.org/10.1371/journal.pone.0014090

Ejemplares similares